CPEX Pharmaceuticals’s Nasulin Insulin Therapy Featured in an Oral Presentation and Four Abstracts at the Ninth Annual Diabetes Technology Meeting
11/5/2009 10:11:24 AM
More...
|
CPEX Pharmaceuticals Reports Third-Quarter 2009 Financial Results
11/4/2009 9:06:30 AM
More...
|
CPEX Pharmaceuticals to Present at Ninth Annual Diabetes Technology Meeting
9/15/2009 9:38:31 AM
More...
|
CPEX Pharmaceuticals Reports Second-Quarter 2009 Financial Results
8/5/2009 9:32:30 AM
More...
|
CPEX Pharmaceuticals Reports First-Quarter 2009 Financial Results
5/6/2009 8:51:25 AM
More...
|
CPEX Pharmaceuticals Reports 2008 Fourth Quarter and Year-End Financial Results
3/5/2009 9:05:09 AM
More...
|
CPEX Pharmaceuticals Announces Completion of Phase 2 Trial for Urology Drug by Serenity Pharmaceuticals
2/26/2009 9:42:36 AM
More...
|
CPEX Pharmaceuticals Initiates Phase II Clinical Trial of Nasulin(R)
2/24/2009 9:22:19 AM
More...
|
CPEX Pharmaceuticals to Present at the 11th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/4/2009 8:52:59 AM
More...
|
CPEX Pharmaceuticals Announces Appointment of New Chief Medical Officer
2/2/2009 9:35:06 AM
More...
|
|